Cancer cell metabolism: implications for therapeutic targets
about
Glucose metabolism in gastric cancer: The cutting-edgeMitochondrial Dysfunction in Cancer and Neurodegenerative Diseases: Spotlight on Fatty Acid Oxidation and Lipoperoxidation ProductsThe Warburg effect and drug resistanceRestoration of mitochondria function as a target for cancer therapyCancer stem cell metabolism: a potential target for cancer therapyReactive oxygen species are required for driving efficient and sustained aerobic glycolysis during CD4+ T cell activation.Ursolic acid-mediated changes in glycolytic pathway promote cytotoxic autophagy and apoptosis in phenotypically different breast cancer cells.Network topology-based detection of differential gene regulation and regulatory switches in cell metabolism and signalingDeguelin inhibits non-small cell lung cancer via down-regulating Hexokinases II-mediated glycolysis.Kaposi's sarcoma herpesvirus microRNAs induce metabolic transformation of infected cellsGlycolysis, tumor metabolism, cancer growth and dissemination. A new pH-based etiopathogenic perspective and therapeutic approach to an old cancer questionMethods to study the tumor microenvironment under controlled oxygen conditions.Proteome-metabolome profiling of ovarian cancer ascites reveals novel components involved in intercellular communication.Targeting the facilitative glucose transporter GLUT1 inhibits the self-renewal and tumor-initiating capacity of cancer stem cells.Cancer stratification by molecular imaging.Monocarboxylate transporter 1 inhibitors as potential anticancer agentsInvestigational cancer drugs targeting cell metabolism in clinical development.Accelerated Lactate Dehydrogenase Activity Potentiates Osteoclastogenesis via NFATc1 Signaling.Hexokinase 2 controls cellular stress response through localization of an RNA-binding proteinPKM2 regulates neural invasion of and predicts poor prognosis for human hilar cholangiocarcinoma.Long Noncoding RNA Ceruloplasmin Promotes Cancer Growth by Altering Glycolysis.Suppression of mitochondrial respiration with auraptene inhibits the progression of renal cell carcinoma: involvement of HIF-1α degradation.The expression pattern of PFKFB3 enzyme distinguishes between induced-pluripotent stem cells and cancer stem cells.5-fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like traits.Monitoring cancer stem cells: insights into clinical oncology.EMT-induced metabolite signature identifies poor clinical outcome.Targeting glucose metabolism in cancer: new class of agents for loco-regional and systemic therapy of liver cancer and beyond?Re-programming tumour cell metabolism to treat cancer: no lone target for lonidamineDecreased glutathione biosynthesis contributes to EGFR T790M-driven erlotinib resistance in non-small cell lung cancer.Formal modeling and analysis of the hexosamine biosynthetic pathway: role of O-linked N-acetylglucosamine transferase in oncogenesis and cancer progression.TIGAR cooperated with glycolysis to inhibit the apoptosis of leukemia cells and associated with poor prognosis in patients with cytogenetically normal acute myeloid leukemiaMetformin increases PDH and suppresses HIF-1α under hypoxic conditions and induces cell death in oral squamous cell carcinoma.2-Deoxyglucose and sorafenib synergistically suppress the proliferation and motility of hepatocellular carcinoma cells.MiRNA-543 promotes osteosarcoma cell proliferation and glycolysis by partially suppressing PRMT9 and stabilizing HIF-1α protein.Tumor glycolysis as a target for cancer therapy: progress and prospects.The role of PML in hematopoietic and leukemic stem cell maintenance.Metabolic isoenzyme shifts in cancer as potential novel therapeutic targets.Dysregulated glycolysis as an oncogenic event.Effects of deranged metabolism on epigenetic changes in cancer.Metformin, an old drug, brings a new era to cancer therapy
P2860
Q26766098-1E8AE7B0-90AC-4D69-8053-E38873A46CFAQ26767051-2C213BED-9924-44E6-B74F-030D2307CB77Q26770007-911E9D94-3905-48D3-B0D2-229B059B5AB2Q26864167-8F844C3D-9166-48DE-8020-D4570C436D72Q28079045-2A2FB4CD-DBCF-4CB3-BA00-A50ECEF45443Q33584702-3E46B261-350C-4859-A17E-CB18A5821935Q33592858-25AF13A5-6F67-4487-BBFE-03F360BFDD12Q33650449-B2524091-9ABB-4A3E-ABD6-DE55053C896EQ33779169-2535EF9E-EB13-4BEB-AEF5-C9B398676885Q34257830-56DCB08E-8B7D-40AA-9E95-4C6CF0A1A613Q34459681-2AE206C9-5238-4A64-8ADC-06D8058C650DQ34622961-17E05C10-B4E9-477B-9EF5-72186A59AF39Q34634997-6E5ADDD7-C6D1-4158-B9E9-5F3804463492Q35176105-AD5CAE8A-7B84-4316-88D2-C79A3A493583Q35380664-626F5842-C921-4E22-982D-C438346FE6B3Q35615147-91734AE4-3E6E-4145-AAB7-7D5FBDAAF674Q35615701-AEEC83FB-19C9-4BA0-BBCF-43FE1159AFBEQ35989618-CE0CF7BE-FFD9-4300-8992-8C8CE67D07EEQ36022268-899969B1-5302-4CAE-9EF0-5641F65F6C61Q36292690-41CAC8E2-14B8-4643-9B89-5C8B4E6A6F80Q36405508-462241CD-F146-4DAA-8C03-C462051111F8Q36545983-46C88164-0B3C-4EE2-B00F-7823635BF23BQ36557422-F91913FB-DA69-49A2-8B07-69ACE523A03EQ36561571-504FBF5D-0C0E-4711-B88D-34CF789EE336Q36585140-E6C6D000-C914-43E1-99A8-EC9F3E98CBAEQ36618962-D30E5490-A1EE-4422-A879-6E536F5F242DQ36687966-1FA1EA57-442A-4B34-9008-6B23574359A9Q36955054-D5A5F079-153D-4563-ADF6-86B10DC1C58DQ37285973-1CCF5027-F9D6-4C0E-8EDE-788EC752491BQ37305086-C057834D-66FA-40FB-B36D-EEF5C60BAB40Q37440458-0E53EB5B-C85E-4FC2-8677-F44EE3A0866FQ37688194-E3303ACD-8E33-4AB8-B4BD-8487283A2426Q37701242-56E5731D-1084-4307-835E-0850A3016C6BQ37709281-48F3651A-E756-4B15-8BCF-338C3979FCC2Q38168262-5DF76DEE-90C2-4C6D-B2E9-BC43FDA54F0FQ38184494-6E4EDC36-357D-47B7-836D-DE3CDBD1AE13Q38268052-D308285A-522E-4F70-BAB3-2587A0405276Q38327525-3A7C4D8C-F55E-4717-98DD-A9D412430A86Q38335029-B2131648-BE19-403F-A228-82FF2DD496DCQ38393435-555757D5-8DA0-48B3-93F4-134771C2F752
P2860
Cancer cell metabolism: implications for therapeutic targets
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Cancer cell metabolism: implications for therapeutic targets
@ast
Cancer cell metabolism: implications for therapeutic targets
@en
Cancer cell metabolism: implications for therapeutic targets
@nl
type
label
Cancer cell metabolism: implications for therapeutic targets
@ast
Cancer cell metabolism: implications for therapeutic targets
@en
Cancer cell metabolism: implications for therapeutic targets
@nl
prefLabel
Cancer cell metabolism: implications for therapeutic targets
@ast
Cancer cell metabolism: implications for therapeutic targets
@en
Cancer cell metabolism: implications for therapeutic targets
@nl
P2860
P3181
P356
P1476
Cancer cell metabolism: implications for therapeutic targets
@en
P2093
Jinhwa Lee
Miran Jang
P2860
P2888
P3181
P356
10.1038/EMM.2013.85
P407
P50
P5008
P577
2013-10-04T00:00:00Z
P5875
P6179
1032847156